Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Adenosine Receptor A3 (ADORA3) - Pipeline Review, H2 2016 - Key Vendors are Can-Fite BioPharma & Huons - Research and Markets

Research and Markets
Posted on: 19 Oct 16

Research and Markets has announced the addition of the "Adenosine Receptor A3 (ADORA3) - Pipeline Review, H2 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for HAdenosine Receptor A3 (ADORA3) , complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for HAdenosine Receptor A3 (ADORA3) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • Can-Fite BioPharma Ltd.
  • Huons Co., Ltd.

Key Topics Covered:

  • Introduction
  • HAdenosine Receptor A3 (ADORA3) Overview
  • Therapeutics Development
  • Pipeline Products for HAdenosine Receptor A3 (ADORA3) - Overview
  • Pipeline Products for HAdenosine Receptor A3 (ADORA3) - Comparative Analysis
  • HAdenosine Receptor A3 (ADORA3) - Therapeutics under Development by Companies
  • HAdenosine Receptor A3 (ADORA3) - Therapeutics under Investigation by Universities/Institutes
  • HAdenosine Receptor A3 (ADORA3) - Pipeline Products Glance
  • Late Stage Products
  • Clinical Stage Products
  • Early Stage Products
  • HAdenosine Receptor A3 (ADORA3) - Products under Development by Companies
  • HAdenosine Receptor A3 (ADORA3) - Products under Investigation by Universities/Institutes
  • HAdenosine Receptor A3 (ADORA3) - Companies Involved in Therapeutics Development

For more information about this report visit http://www.researchandmarkets.com/research/59nsds/adenosine

View source version on businesswire.com: http://www.businesswire.com/news/home/20161019006174/en/

Business Wire
www.businesswire.com

Last updated on: 19/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.